In addition, the drug mechanism by which PFD exhibits the protective effects on pulmonary fibrosis in rats through inhibiting the NF‐κB and MAPK signaling pathway has become a hot research topic worldwide abroad.20 Here, NFKB1 is linked to polyostotic fibrous dysplasia.